
Leeds maternity
If you have been affected by the issues in this story, you can contact the BBC Action Line here
As well as the new families, three new whistleblowers - two who still work for the trust - have shared concerns about the standard of care at its two maternity units - at the LGI and St James' University Hospital. This is in addition to the two we spoke to in our initial investigation.Both units are rated "good" by the CQC, but the whistleblowers believe that rating does not reflect reality.There was a problem with the culture, one senior staff member told us. "People [staff] are scared to raise concerns because nothing ever happens when they are raised. So there's a 'what's the point' attitude," they said.The BBC has also learned that 107 clinical claims were made against LTH for obstetric-related deaths and injuries between April 2015 and April 2024. This was obtained via a Freedom of Information request to NHS Resolution - the health service's insurance arm.More than £71m was paid during this period including for 14 stillbirths, and 13 fatalities involving mothers or babies. These babies included Tassie's son, Baxter.
'I knew we needed help'
Tassie's care was graded by the trust's review team - which should include an external member - as a D, the lowest possible.It confirmed that "the mother presented with reduced fetal movements but management was not appropriate"."I knew that me and my baby needed help, and I tried to communicate that as clearly as I could, and I didn't get that help," Tassie says. "Labour is painful, but when you know the baby's dead… I can't even explain."The review group also agreed that Tassie should have been offered an induction earlier at 39 weeks given the combined risks of hypertension and growth concerns with her baby.Dr Harrison from the trust said it offered "sincere apologies and condolences" to Ms Weaver and her family for their "distressing experiences and loss".He added: "Immediate internal and external reviews of the care provided were undertaken and we made a number of changes as a result of this tragic case."
In total, 67 families have now told the BBC they experienced inadequate maternity care at Leeds. All are calling for an independent review into its maternity services.Common themes were expressed repeatedly by the 47 new families who contacted the BBC when we spoke to them. These included women feeling like they were not being listened to when they raised concerns, a lack of compassion, and families saying the trust made them feel like they were alone in their experience.One of the families paid an undisclosed settlement was Heidi Mayman and her partner Dale Morton, who gave birth to their first daughter Lyla in 2019, two years before Tassie gave birth to Baxter. Lyla died aged four days.Heidi also believes her concerns were not taken seriously during her "traumatic" labour. Lyla was born in poor condition about 37 hours after Heidi says she first called the LGI's maternity assessment centre, reporting blood and fluid loss. During her labour she also repeatedly raised concerns about reduced fetal movements and worsening pain."I just wish she were here. I feel like it's just ruined our lives, I'll never get over it," Heidi told us.An external investigation following Lyla's death by the Healthcare Safety Investigation Branch (HSIB), identified safety recommendations.Lyla's dad, Dale says reading the investigation, which outlined the protocols the midwives had failed to follow was "just like a catalogue of errors".
'Swept under the carpet'
In January, we reported that 27 stillbirths and 29 neonatal deaths at LTH between 2019 and mid-2024 - and two deaths of mothers - had been judged to have been potentially preventable by a trust review group.The deaths reviewed included babies with congenital abnormalities and newborns and mothers transferred after birth for specialist care. The trust said the number of potentially-avoidable neonatal deaths had been "very small".Following our report, a group of parents wrote to Health Secretary Wes Streeting calling for an urgent review into Leeds' maternity services following the BBC investigation, to be led by senior midwife Donna Ockenden. He has written to the families but not yet made a decision.We have now spoken to a total of five whistleblowers, three still working for the trust, who have echoed concerns raised by families.One of them is a senior clinical staff member who told us they have seen "near misses" because of inadequate staffing levels.They also recalled an incident, in which a baby died, which they believe could have been prevented if issues had been recognised earlier during the labour.This staff member told the BBC the trust does not "learn from their mistakes" and often things are "swept under the carpet".
'Taking concerns very seriously'
A full report of the CQC's findings following its inspection of the trust's maternity and neonatal services, including all action it has told the trust to take, is due to be published shortly.The trust was given immediate feedback regarding urgent concerns which required action to address identified risks, the CQC told us. It also took enforcement action requiring the implementation of safe staffing levels.Two months after our initial report, NHS England placed the trust under its maternity safety support programme (MSSP) which works to improve trusts where serious concerns have been identified."We are taking the concerns raised by families about the quality and safety of maternity care in Leeds incredibly seriously," chief midwifery officer for England, Kate Brintworth, said.LTH's Dr Magnus Harrison said in a statement: "We are fully committed to ensuring that every family receives safe, respectful and compassionate care. We recognise we need to make improvements."He added: "We have commissioned an independent external review to complement NHS England's Peer Quality Review of our neonatal services, so that we can better understand the data on neonatal outcomes."
Do you have more information about this story?You can reach Divya directly and securely through encrypted messaging app Signal on: +44 7961 390 325, by email at divya.talwar@bbc.co.uk, or her Instagram account.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Sun
35 minutes ago
- The Sun
University puts up ‘bonkers' posters warning its students not to eat conkers
A UNIVERSITY launched a 'bonkers' campaign warning its students not to eat conkers. East Anglia University has put up posters showing a conker in a red circle with a cross through it. Above the image is written, 'Do not eat conkers!' and below, 'These are not chestnuts and eating them will make you unwell'. Bosses put up the posters in the international student study centre fearing a new intake of Chinese students might think they are edible. Around 1,000 of the 17,000 students at the Norwich university hail from China. It is feared some new arrivals could confuse conkers — known as horse chestnuts — with water chestnuts, which are prized in China for their crunchy texture and mild sweetness. Horse chestnuts, however, contain a toxin called aesculin which can cause abdominal pain, nausea and vomiting. A source said: 'The uni looks out for student welfare and thought this was an area they may need guidance on.' The university said: 'As far as we're aware, no students have attempted to eat conkers and we'd like to keep it that way. 'The posters were prompted by a member of staff who previously worked with Chinese students and recalled similar confusion elsewhere. 'It's part of our broader commitment to student wellbeing.'


Daily Mirror
an hour ago
- Daily Mirror
Weight loss pill that helped patients shift 12% of body mass may soon be on NHS
A weight-loss tablet, which could be a cheaper and easier alternative to jabs and has seen patients during a trial lose up to almost 2st, could soon be available on the NHS A powerful new generation of weight-loss pill that could provide hope for millions of patients is set to be considered by regulators for NHS approval. A trial found overweight people taking the medication lost up to almost 2st – or 12% of their body weight – after 18 months. The maker, US firm Lilly, said it will seek the go-ahead by regulators for the drug orforglipron. It could be a cheaper and easier alternative to weight-loss jabs, which have to be refrigerated. The daily tablet is a GLP-1 agonist, which can cut appetite. Like jabs, the pill mimics the effects of hormones that make us feel full. Lilly also makes weight-loss jab Mounjaro. It comes after the NHS warned mouth symptom could be life-shortening disease. Kenneth Custer, of Lilly, said: 'We're working to transform obesity care with a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments. 'We are planning to submit orforglipron for regulatory review by year-end.' It will need to be approved as safe by the Medicines and Healthcare products Regulatory Agency before the National Institute for Health and Care Excellence decides if it is cost-effective for the NHS. The Mirror understands guidance is expected next year on whether it will be available on the health service. The study found 60% of people on the highest dose of orforglipron lost at least 10% of their body weight. While 40% of people shed at least 15% of their body weight. The study of 3,127 overweight adults also found benefits such as better cholesterol. Lilly said the safety profile of the tablet is similar to other GLP-1 drugs, with gastrointestinal issues the most common side effect. Dr Simon Cork, senior lecturer in physiology at Anglia Ruskin University, said: 'These early results on the effectiveness of orforglipron in promoting clinically significant weight loss are a positive step forward in the development of this class of drugs. 'Their effects on weight loss are not as profound as that seen in [jabs]. 'Nevertheless, that this medication is an oral form, rather than injectable, will likely be seen as more tolerable for many. Manufacturing costs are also anticipated to be significantly lower.' An estimated 1.5 million people in the UK use weight-loss medication, most privately. Mounjaro was due to be rolled out across the NHS in England from June 23 for those with the highest clinical need, but a probe found only eight of 42 NHS integrated care boards are providing it at present. Nearly half of boards say they will cap the number they treat due to lack of funding. NHS England says the plan is for jabs to bemore widely available. Figures suggest about 29% of adults are obese. Another new study has found GLP-1s may have other benefits such as improving Alzheimer's and liver disease.


Daily Mail
an hour ago
- Daily Mail
Long NHS waiting lists bolster profits at BUPA as it cashes in on 'growing demand' for private care
Bupa is on course to make bumper profits this year as it cashes in on 'growing demand' for private care because of lengthy NHS waiting lists. The health insurer reported a pre-tax profit of £501million for the first six months of 2025, 19 per cent higher than last year. The results, which also saw an 11 per cent jump in revenue to £8.8billion for the first half of 2025, included Bupa's operations in Europe, Latin America, India, the Middle East and Asia. The company said its performance had been bolstered by surging demand for private healthcare and income from its care homes. Inaki Ereno, group chief executive, said: 'In the first six months of the year, we have served more customers than ever before.' The half-year report also revealed that the number of people taking out Bupa's health insurance globally rose 23 per cent to 40.9m, while the occupancy rate of its care homes for older people rose 1 per cent to 94 per cent. Its UK and India division recorded turnover of £2.8billion, while profits soared 89 per cent to £126million. UK insurance accounted for 48 per cent of the division's sales, while 9 per cent came from dental practices. The company has opened 61 sites around the world, including buying New Victoria Hospital, London, its first UK hospital purchase since 2008. The growth comes as people turn to private healthcare to avoid joining the 6.2m patients languishing on NHS waiting lists. The figures, revealed last week, also showed that nearly 3m patients awaiting care had not received a first appointment with a specialist or a diagnostic test since their referral. The Patients Association described the 'invisible waiting list crisis' as 'staggering', as millions are left in limbo while their health deteriorates. Other companies which have benefited from the boom in demand from those wanting to go private include Spire, Nuffield and Circle. David Rowland, director of think-tank Centre for Health and the Public Interest, told The Guardian: 'You've now got more and more people who are having to pay out of their own pockets for things like dental care or operations that aren't available on the NHS. 'Nobody's being honest about the extent to which this is happening. No politician has stood up and advocated for it. It's a trend which has been happening increasingly over the past 30 years with Labour, Conservative and Lib Dem parties in charge.' The General Medical Council recently revealed that 19 per cent of doctors are considering a move abroad – believing the profession is 'treated better' in other countries and better-paid.